JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform Following Acquisition Offer
Tweet Send to a Friend
JMP Securities analyst Liisa Bayko downgraded Achillion Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
